Effect of vitamin K on bone mineral density and fractures in adults: an updated systematic review and meta-analysis of randomised controlled trials A. MottT. BradleyD. J. Torgerson Review Article 10 May 2019 Pages: 1543 - 1559
Vertebral bone attenuation in Hounsfield Units and prevalent vertebral fractures are associated with the short-term risk of vertebral fractures in current and ex-smokers with and without COPD: a 3-year chest CT follow-up study M.J. van DortJ.H.M. DriessenJ.P.W. van den Bergh Original Article Open access 03 June 2019 Pages: 1561 - 1571
A case-control pilot study of stress fracture in adolescent girls: the discriminative ability of two imaging technologies to classify at-risk athletes R. L. DuckhamS. R. BialoC. M. Gordon Original Article 29 May 2019 Pages: 1573 - 1580
Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis W. ZhouY. LiuD. Geng Original Article 21 May 2019 Pages: 1581 - 1589
Correlation between hip osteoarthritis and proximal femoral fracture site: could it be protective for intracapsular neck fractures? A retrospective study on 320 cases Tommaso MalutaGiovanna TosoBruno Magnan Original Article 08 June 2019 Pages: 1591 - 1596
Challenges and opportunities to improve fracture liaison service attendance: fracture registration and patient characteristics and motivations P. van den BergP.M.M. van HaardD.H. Schweitzer Original Article 25 May 2019 Pages: 1597 - 1606
Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia H. ChandlerD.J. BrooksB. Lanske Original Article Open access 03 May 2019 Pages: 1607 - 1616
Increased risk of osteoporotic vertebral fracture in rheumatoid arthritis patients with new-onset cardiovascular diseases: a retrospective nationwide cohort study in Taiwan W.-J. HongW. ChenJ.-L. Lan Original Article 24 May 2019 Pages: 1617 - 1625
Patients’ reasons for adhering to long-term alendronate therapy J. PepeC. CiprianiS. Minisola Original Article 14 May 2019 Pages: 1627 - 1634
Longitudinal assessment of health-related quality of life in osteoporosis: data from the population-based Canadian Multicentre Osteoporosis Study W.M. HopmanC. BergerThe CaMos Research Group Original Article 08 May 2019 Pages: 1635 - 1644
Dietary inflammatory index® and cortical bone outcomes in healthy adolescent children L. M. CoheleyN. ShivappaR. D. Lewis Original Article 29 May 2019 Pages: 1645 - 1654
High FGF23 levels are associated with impaired trabecular bone microarchitecture in patients with osteoporosis T. RuppS. ButscheidtT. Rolvien Original Article 01 May 2019 Pages: 1655 - 1662
Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures M. H. JensenP. Vestergaard Original Article 25 May 2019 Pages: 1663 - 1670
Five-year refracture rates of a province-wide fracture liaison service R. SujicD.E. Beatonthe Ontario Osteoporosis Strategy Fracture Screening and Prevention Program Evaluation Team Original Article 31 May 2019 Pages: 1671 - 1677
Distal radius and tibia bone microarchitecture impairment in female patients with diffuse systemic sclerosis M. M. Sampaio-BarrosJ. C. AlvarengaR. M. R. Pereira Original Article 27 April 2019 Pages: 1679 - 1691
Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study M.W. ArefE.A. SwallowM.R. Allen Short Scientific Communication 08 May 2019 Pages: 1693 - 1698
Diffuse osteosclerosis as a presentation of recurrent breast cancer: role of endothelin 1 K. G. ZarneckiJ. KristiantoJ. L. Shaker Case Report 11 May 2019 Pages: 1699 - 1703
Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis S. NoeH. JaegerE. Wolf Letter to the Editor 29 May 2019 Pages: 1705 - 1706
Reply to “Antiretroviral therapy options in people living with HIV at risk of or with osteoporosis. Comment on: Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against Osteoporosis” by S. Noe, H. Jaeger, E. Wolf E. BiverA. CalmyC. Meier Letter to the Editor 29 May 2019 Pages: 1707 - 1707
Glucagon-like peptide-1 receptor agonists and fracture risk—limitations to current knowledge K. HygumT. HarsløfJ. Starup-Linde Letter to the Editor 22 May 2019 Pages: 1709 - 1710